Uveitis and neurologic diseases: An often overlooked relationship

Wiener Klinische Wochenschrift

Volumn 118, Issue 9-10, 2006, Pages 273-279

  Maca, Saskia M ^a   Scharitzer, Martina ^a   Barisani Asenbauer, Talin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Etiology; Neurologic complications; Neurologic disease; Uveitis; Uveomeningeal syndromes

Indexed keywords

ADOLESCENT; ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; BEHCET DISEASE; BORRELIA INFECTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; EYE INFLAMMATION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNE MEDIATED INJURY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEASLES; MENINGOENCEPHALITIS; MULTIPLE SCLEROSIS; MUMPS; NEUROLOGIC DISEASE; NEUROSYPHILIS; OPHTHALMOLOGY; ORBIT PSEUDOTUMOR; SARCOIDOSIS; UVEITIS; VOGT KOYANAGI SYNDROME;

AUSTRIA; COMORBIDITY; HUMANS; INCIDENCE; NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATISTICS; UVEITIS;

EID: 33745745580     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0601-6     Document Type: Article

References (27)

1. Bloch-Michel E, Nussenblatt RB (1987) International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103: 234-235
2. Zierhut M (2002) Uveitis, Bd 1. Differentialdiagnose. Kohlhammer, Stuttgart
3. Forster DJ (1999) General approach to the uveitis patient and treatment strategies. In: Yanoff M, Duker JS (eds) Ophthalmology. Mosby, London, ch 3.1-3.6
4. Moorthy RS, Rao NA (1997) Approach to the uveitis patient. In: Wright KW (ed) Textbook of ophthalmology. Williams and Wilkins, Baltimore, pp 481-486
5. Rodriguez A, Calonge M, Pedroza-Seres M, Akova YA, Messmer EM, D'Amico DJ, et al (1996) Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 114: 593-599
6. Janigian RH, Young D (2005) Uveitis, evaluation and treatment, www.emedicine.com
7. Schmutzhard E (2002) Multiple sclerosis and Lyme borreliosis. Wien Klin Wochenschr 114: 539-543
8. Kieseier BC, Archelos JJ, Storch M, Gold R, Hartung HP (1999) The immunopathogenesis of multiple sclerosis. A survey of recent advances and implications for future therapy. Wien Klin Wochenschr 111: 728-737
9. Berile GR, Flynn TE (1997) Syphilis exposure in patients with uveitis. Ophthalmology 104: 1605-1609
10. Ho AC, Guyer DR, Yannuzzi LA (1993) Ocular syphilis: classic manifestations and recent observations. Semin Ophthalmol 8: 53-60
11. Hunfeld KP, Ernst M, Zachary P, Jaulhac B, Sonneborn HH, Brade V (2002) Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease. Wien Klin Wochenschr 114: 580-585
12. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452
13. Comu S, Verstraeten T, Rinkoff JS (1996) Neurologic manifestations in acute posterior multifocal placoid pigment epitheliopathy. Stroke 27: 996-1001
14. Brazis PW, Stewart M, Lee AG (2004) The uveomeningeal syndromes. Neurologist 10: 171-184
15. Smith JR, Rosenbaum JT (2004) Neurologic concomitants of uveitis. Br J Ophthalmol 88: 1498-1499
16. Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12: 137-142
17. Arnold AC (2005) Evolving management of optic neuritis and multiple sclerosis. Am J Opthalmol 139: 1101-1108
18. Prieto JF, Dios E, Gutierrez JM, Mayo A, Calonge M, Herreras JM (2001) Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 9: 93-102
19. Towler HM, Lightman S (2000) Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol 28: 97-102
20. Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, et al (2004) Escalating immunotherapy of multiple sclerosis-new aspects and practical application. J Neurol 251: 1329-1339
21. Becker MD, Heiligenhaus A, Hudde T, Storch-Hagenlocher B, Wildemann B, Barisani-Asenbauer T, et al (2005) Interferon as a treatment for uveitis associated with multiple sclerosis. Br J Ophthalmol 89: 1254-1257
22. Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44: 2862-2869
23. Wechsler B, Sable-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, et al (2004) Infliximab in refractory uveitis due to Behcet's disease. Clin Exp Rheumatol 22: 14-16
24. Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP (2004) Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol 138: 648-650
25. Benitez-Del-Castillo JM, Martinez-De-La-Casa JM, Pato-Cour E, Mendez-Femandez R, Lopez-Abad C, Matilla M, et al (2004) Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab). Eye 19: 841-845
26. Kleinert J, Lorenz M, Kostler W, Horl W, Sunder-Plassmann G, Soleiman A (2004) Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade. Wien Klin Wochenschr 116: 334-338
27. Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, et al (1999) Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 106: 1805-1810